Happy New Year everyone.
Acadia has forecast a more linear growth trend over the next few quarters. I believe this will be the case for the next quarter especially having the holiday period included.
However a reminder that there will still be some larger influx of patients like the group who will be given the all clear tomorrow.
MassHealth (Boston children’s hospital) is a centre of excellence in Massachusetts who treat over 250 Rett patients.
They received notice recently that Daybue will be listed on the MassHealth Drug list from January 2, 2024
Daybue Rollout, page-117
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |